168 related articles for article (PubMed ID: 25881827)
1. Synthesis and antimalarial evaluation of prodrugs of novel fosmidomycin analogues.
Faísca Phillips AM; Nogueira F; Murtinheira F; Barros MT
Bioorg Med Chem Lett; 2015; 25(10):2112-6. PubMed ID: 25881827
[TBL] [Abstract][Full Text] [Related]
2. Prodrugs of reverse fosmidomycin analogues.
Brücher K; Gräwert T; Konzuch S; Held J; Lienau C; Behrendt C; Illarionov B; Maes L; Bacher A; Wittlin S; Mordmüller B; Fischer M; Kurz T
J Med Chem; 2015 Feb; 58(4):2025-35. PubMed ID: 25633870
[TBL] [Abstract][Full Text] [Related]
3. Double ester prodrugs of FR900098 display enhanced in-vitro antimalarial activity.
Wiesner J; Ortmann R; Jomaa H; Schlitzer M
Arch Pharm (Weinheim); 2007 Dec; 340(12):667-9. PubMed ID: 17994601
[TBL] [Abstract][Full Text] [Related]
4. Amino acid based prodrugs of a fosmidomycin surrogate as antimalarial and antitubercular agents.
Courtens C; Risseeuw M; Caljon G; Maes L; Martin A; Van Calenbergh S
Bioorg Med Chem; 2019 Mar; 27(5):729-747. PubMed ID: 30692024
[TBL] [Abstract][Full Text] [Related]
5. Conformationally restrained aromatic analogues of fosmidomycin and FR900098.
Kurz T; Schlüter K; Pein M; Behrendt C; Bergmann B; Walter RD
Arch Pharm (Weinheim); 2007 Jul; 340(7):339-44. PubMed ID: 17611943
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antimalarial activity of chain substituted pivaloyloxymethyl ester analogues of Fosmidomycin and FR900098.
Kurz T; Schlüter K; Kaula U; Bergmann B; Walter RD; Geffken D
Bioorg Med Chem; 2006 Aug; 14(15):5121-35. PubMed ID: 16679022
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of alpha-substituted fosmidomycin analogues as highly potent Plasmodium falciparum growth inhibitors.
Haemers T; Wiesner J; Van Poecke S; Goeman J; Henschker D; Beck E; Jomaa H; Van Calenbergh S
Bioorg Med Chem Lett; 2006 Apr; 16(7):1888-91. PubMed ID: 16439126
[TBL] [Abstract][Full Text] [Related]
8. Acyloxyalkyl ester prodrugs of FR900098 with improved in vivo anti-malarial activity.
Ortmann R; Wiesner J; Reichenberg A; Henschker D; Beck E; Jomaa H; Schlitzer M
Bioorg Med Chem Lett; 2003 Jul; 13(13):2163-6. PubMed ID: 12798327
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of alpha,beta-unsaturated alpha-aryl-substituted fosmidomycin analogues as DXR inhibitors.
Devreux V; Wiesner J; Jomaa H; Van der Eycken J; Van Calenbergh S
Bioorg Med Chem Lett; 2007 Sep; 17(17):4920-3. PubMed ID: 17583502
[TBL] [Abstract][Full Text] [Related]
10. gamma-Substituted bis(pivaloyloxymethyl)ester analogues of fosmidomycin and FR900098.
Kurz T; Behrendt C; Pein M; Kaula U; Bergmann B; Walter RD
Arch Pharm (Weinheim); 2007 Dec; 340(12):661-6. PubMed ID: 17994605
[TBL] [Abstract][Full Text] [Related]
11. Double prodrugs of a fosmidomycin surrogate as antimalarial and antitubercular agents.
Courtens C; Risseeuw M; Caljon G; Maes L; Cos P; Martin A; Van Calenbergh S
Bioorg Med Chem Lett; 2019 May; 29(10):1232-1235. PubMed ID: 30879839
[TBL] [Abstract][Full Text] [Related]
12. Synthetic Fosmidomycin analogues with altered chelating moieties do not inhibit 1-deoxy-d-xylulose 5-phosphate Reductoisomerase or Plasmodium falciparum growth in vitro.
Chofor R; Risseeuw MD; Pouyez J; Johny C; Wouters J; Dowd CS; Couch RD; Van Calenbergh S
Molecules; 2014 Feb; 19(2):2571-87. PubMed ID: 24566322
[TBL] [Abstract][Full Text] [Related]
13. Phosphonodiamidate prodrugs of N-alkoxy analogs of a fosmidomycin surrogate as antimalarial and antitubercular agents.
Courtens C; Risseeuw M; Caljon G; Cos P; Martin A; Van Calenbergh S
Bioorg Med Chem Lett; 2019 May; 29(9):1051-1053. PubMed ID: 30857749
[TBL] [Abstract][Full Text] [Related]
14. Arylmethyl substituted derivatives of Fosmidomycin: synthesis and antimalarial activity.
Schlüter K; Walter RD; Bergmann B; Kurz T
Eur J Med Chem; 2006 Dec; 41(12):1385-97. PubMed ID: 17055117
[TBL] [Abstract][Full Text] [Related]
15. Divergent strategy for the synthesis of alpha-aryl-substituted fosmidomycin analogues.
Devreux V; Wiesner J; Jomaa H; Rozenski J; Van der Eycken J; Van Calenbergh S
J Org Chem; 2007 May; 72(10):3783-9. PubMed ID: 17428097
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and Antiplasmodial Activity of Novel Fosmidomycin Derivatives and Conjugates with Artemisinin and Aminochloroquinoline.
Palla D; Antoniou AI; Baltas M; Menendez C; Grellier P; Mouray E; Athanassopoulos CM
Molecules; 2020 Oct; 25(20):. PubMed ID: 33096817
[TBL] [Abstract][Full Text] [Related]
17. Fosmidomycin for the treatment of malaria.
Wiesner J; Borrmann S; Jomaa H
Parasitol Res; 2003 Jun; 90 Suppl 2():S71-6. PubMed ID: 12937969
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of beta- and gamma-oxa isosteres of fosmidomycin and FR900098 as antimalarial candidates.
Haemers T; Wiesner J; Giessmann D; Verbrugghen T; Hillaert U; Ortmann R; Jomaa H; Link A; Schlitzer M; Van Calenbergh S
Bioorg Med Chem; 2008 Mar; 16(6):3361-71. PubMed ID: 18158249
[TBL] [Abstract][Full Text] [Related]
19. Alkoxycarbonyloxyethyl ester prodrugs of FR900098 with improved in vivo antimalarial activity.
Ortmann R; Wiesner J; Reichenberg A; Henschker D; Beck E; Jomaa H; Schlitzer M
Arch Pharm (Weinheim); 2005 Jul; 338(7):305-14. PubMed ID: 15996004
[TBL] [Abstract][Full Text] [Related]
20. Resistance to the antimicrobial agent fosmidomycin and an FR900098 prodrug through mutations in the deoxyxylulose phosphate reductoisomerase gene (dxr).
Armstrong CM; Meyers DJ; Imlay LS; Freel Meyers C; Odom AR
Antimicrob Agents Chemother; 2015 Sep; 59(9):5511-9. PubMed ID: 26124156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
